Founded in 1992. CMX provides CRO & SMO services for the pharma, biotech and medical device industries. CMX provides Clinical Trial Management (Phase I-IV) in Urology and Uro-Oncology from start to finish. CMX CRAs monitor BA/BE studies in multiple indications at Phase I units in Canada. CMX submits CTA applications to Health Canada and IRB submission. CMX completed 380 studies in pre/ post marketing (Phases I-IV), including First in man studies. CMX has the largest network of community urology sites across Canada.